ArticleTherapeutics and clinical risk management2010

Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis.

Linda L Hushaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.